ILLUMINA, INC. Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature
ILLUMINA, INC. (ILMN) reported Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature of -$8.00 thousand for the 12-month period ending 2017-01-01, per its 10-K filed 2017-02-14.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature · last filed 2017-02-14
- ILLUMINA, INC. adjustments to additional paid in capital, convertible debt with conversion feature for the quarter ending 2017-01-01 was -$44.00K.
- ILLUMINA, INC. adjustments to additional paid in capital, convertible debt with conversion feature for the quarter ending 2016-10-02 was $0.00.
- ILLUMINA, INC. adjustments to additional paid in capital, convertible debt with conversion feature for the quarter ending 2016-07-03 was $0.00.
- ILLUMINA, INC. adjustments to additional paid in capital, convertible debt with conversion feature for the quarter ending 2016-04-03 was $36.00K.
- ILLUMINA, INC. adjustments to additional paid in capital, convertible debt with conversion feature for fiscal 2017 was -$8.00K, a 102.14% decline from fiscal 2016.
- ILLUMINA, INC. adjustments to additional paid in capital, convertible debt with conversion feature for fiscal 2016 was $373.00K.
- ILLUMINA, INC. adjustments to additional paid in capital, convertible debt with conversion feature for fiscal 2014 was -$58.35M.
- ILLUMINA, INC. adjustments to additional paid in capital, convertible debt with conversion feature for fiscal 2012 was -$59.43M.
| Period end | Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature 3 month | Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature 6 month | Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature 9 month | Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature 12 month |
|---|---|---|---|---|
| 2017-01-01 | -$44.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-14 | -$44.00K derived: sum of 2 quarters · filed 2017-02-14 | -$44.00K derived: sum of 3 quarters · filed 2017-02-14 | -$8.00K 10-K · filed 2017-02-14 |
| 2016-10-02 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-08 | $0.00 derived: sum of 2 quarters · filed 2016-11-08 | $36.00K 10-Q · filed 2016-11-08 | |
| 2016-07-03 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-02 | $36.00K 10-Q · filed 2016-08-02 | ||
| 2016-04-03 | $36.00K 10-Q · filed 2016-05-09 | |||
| 2016-01-03 | $373.00K 10-K · filed 2017-02-14 | |||
| 2014-12-28 | -$58.35M 10-K · filed 2017-02-14 | |||
| 2012-01-01 | -$59.43M 10-K · filed 2014-02-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WATERS CORP /DE/ (WAT) | United States | $42.297B | 224.28 |
| AGILENT TECHNOLOGIES, INC. (A) | United States | $48.720B | 27.14 |
| METTLER TOLEDO INTERNATIONAL INC/ (MTD) | $30.436B | 30.62 | |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |